Kennedy Capital Management’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-29,179
Closed -$48K 711
2016
Q2
$48K Sell
29,179
-98,688
-77% -$171K ﹤0.01% 700
2016
Q1
$214K Sell
127,867
-22,643
-15% -$45.6K ﹤0.01% 718
2015
Q4
$316K Sell
150,510
-150,701
-50% -$291K 0.01% 713
2015
Q3
$587K Sell
301,211
-126,171
-30% -$289K 0.01% 684
2015
Q2
$1.19M Sell
427,382
-72,618
-15% -$200K 0.02% 660
2015
Q1
$1.2M Buy
+500,000
New +$1.66M 0.02% 639

Other funds holding APYX

Kennedy Capital Management's APYX Position: Q3 2016 in Review

Kennedy Capital Management sold out of Apyx Medical (APYX) in Q3 2016, closing a stake of 29,179 shares — an estimated $48K sold.

Kennedy Capital Management first reported a position in APYX in Q1 2015 and held it in 6 quarters. The position peaked at $1.2M in Q1 2015. 37 funds tracked by Wall St. Rank hold APYX as of Q3 2016.

  • Kennedy Capital Management reported no remaining Apyx Medical position as of Q3 2016 after selling out during the quarter.
  • Kennedy Capital Management sold 29,179 Apyx Medical shares in Q3 2016, an estimated $48K.
  • Kennedy Capital Management first reported a position in Apyx Medical in Q1 2015 and held it in 6 quarters.
  • Kennedy Capital Management's Apyx Medical position peaked at $1.2M in Q1 2015.
  • 37 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2016.

Based on Kennedy Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.